HealthLeaders Podcast Podcast Por HealthLeaders Podcast arte de portada

HealthLeaders Podcast

HealthLeaders Podcast

De: HealthLeaders Podcast
Escúchala gratis

The healthcare industry’s leading source for news, intelligence, and strategy for senior executives.All rights reserved Economía
Episodios
  • Interoperability That Pays Off: Turning Data Exchange Into ROI

    Interoperability That Pays Off: Turning Data Exchange Into ROI
    Feb 13 2026
    Muhammed Chebli, vice president of product, interoperability at NextGen Healthcare, joins HealthLeaders editor Jay Asser to break down how to translate interoperability from an IT initiative into measurable business value.
    Más Menos
    23 m
  • Proving the ROI of Nurse Residency and Leadership Development

    Proving the ROI of Nurse Residency and Leadership Development
    Jan 6 2026
    Evy Olson, vice president of nursing programs at Vizient, joins HealthLeaders editor Jay Asser to discuss how evidence-based nurse residency and leadership transition programs are a workforce necessity that help healthcare organizations address turnover, strengthen leadership pipelines, and sustain care quality.
    Más Menos
    17 m
  • How Multi-Cancer Blood Tests Are Changing Early Detection

    How Multi-Cancer Blood Tests Are Changing Early Detection
    Dec 16 2025
    Cancer screening is evolving beyond a single-organ approach to an approach that evaluates multiple organs throughout the entirety of the body with a simple blood test. In this episode, Dr. Michelle Beidelschies shares how Cancerguard can help health systems detect more cancers earlier, reduce late-stage diagnoses, and improve outcomes. We explore the clinical, operational, and financial implications of adopting multi-cancer early detection testing at scale. Information presented is not clinical, diagnostic, or treatment advice for any particular patient. Providers should use their clinical judgement and experience when deciding how to diagnose or treat patients. Exact Sciences does not recommend or endorse any particular course of treatment or medical choice. The Cancerguard test was developed, and the performance characteristics validated by Exact Sciences Laboratories following College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) regulations. This test has not been cleared or approved by the US Food and Drug Administration. The test is performed at Exact Sciences Laboratories. Exact Sciences Laboratories is accredited by CAP, certified under CLIA regulations, and qualified to perform high-complexity clinical laboratory testing.
    Más Menos
    20 m
Todavía no hay opiniones